Role of natural killer cells in innate resistance to protozoan infections

Current Opinion in Immunology

Volumn 9, Issue 1, 1997, Pages 44-51

  Scharton Kersten, Tanya M ^a   Sher, Alan ^a  

^a Sect Clin and Exp Neuropsychol   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

CELL INTERACTION; HOST RESISTANCE; INFECTION RESISTANCE; KILLER CELL; MACROPHAGE; PROTOZOAL INFECTION; PROTOZOON; REVIEW;

EID: 0031051783     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80157-4     Document Type: Article

References (86)

1. Scott P, Trinchieri G. The role of natural killer cells in host-parasite interactions. of outstanding interest Curr Opin Immunol. 7:1995;34-40 A comprehensive review of NK cell function in infectious disease with an emphasis on NK cell regulation of the adaptive immune response.
2. - cells, which are highly enriched for NK cell lytic activity, are a primary source of IFN-γ early in infection in C3H/HeN mice.
3. Bancroft GJ. The role of natural killer cells in innate resistance to infection. Curr Opin Immunol. 5:1993;503-510.
4. Eugui EM, Allison AC. Differences in susceptibility of various mouse strains to haemoprotozoan infections: possible correlation with natural killer activity. Parasite Immunol. 4:1980;277-292.
5. Rohlman VC, Kuhls TL, Mosier DA, Crawford DL, Greenfield RA. Cryptosporidium parvum infection after abrogation of natural killer cell activity in normal and severe combined immunodeficiency mice. J Parasitol. 79:1993;295-297.
6. Lillehoj HS. Intestinal intraepithelial and splenic natural killer cell responses to Eimerian infections in chickens. Infect Immun. 57:1989;1979-1984.
7. Smith AL, Rose ME, Wakelin D. The role of natural killer cells in resistance to coccidiosis: investigations in a murine model. Clin Exp Immunol. 97:1994;273-279.
8. Evans DL, Cooper EL. Natural killer cells in ectothermic vertebrates. Bioscience. 40:1990;745-749.
9. Kirkpatrick CE, Farrell JP. Leishmaniasis in beige mice. Infect Immun. 38:1982;1208-1216.
10. Ojo-Amaize EA, Vilcek J, Cochrane AH, Nussenzweig RS. Plasmodium berghei sporozoites are mitogenic for murine T cells, induce interferon and activate natural killer cells. J Immunol. 133:1984;1005-1009.
11. Preston PM, Fell AH. Proliferation of Theileria annulata and Theileria parva macroschizont-infected bovine cells in scid mice. Int J Parasit. 23:1993;77-87.
12. Kamiyama T, Hagiwara T. Augmented followed by suppressed levels of natural cell-mediated cytotoxicity in mice infected with Toxoplasma gondii. Infect Immun. 36:1982;628-636.
13. Hauser WE, Sharma SD, Remington JS. Natural killer cells induced by acute and chronic Toxoplasma infection. Cell Immunol. 69:1982;330-346.
14. Hatcher FM, Kuhn RE, Cerrone MC, Burton RC. Increased natural killer cell activity in experimental American trypanosomiasis. J Immunol. 127:1981;1126-1130.
15. Albright JW, Hatcher FM, Albright JF. Interaction between murine natural killer cells and trypanosomes of different species. Infect Immun. 44:1994;315-319.
16. Hatcher FM, Kuhn RE. Destruction of Trypansoma cruzi by natural killer cells. Science. 218:1982;295-296.
17. Hauser WE, Tsai V. Acute toxoplasma infection of mice induces spleen NK cells that are cytotoxic for T. gondii in vitro. J Immunol. 136:1986;313-319.
18. Goyal M, Ganguly NK, Mahajan RC. Natural killer cell cytotoxicity against Toxoplasma gondii in acute and chronic murine toxoplasmosis. Med Sci Res. 16:1988;375-377.
19. Orago AS, Facer CA. Cytotoxicity of human natural killer (NK) cell subsets for Plasmodium falciparum erythrocytic schizonts: stimulation by cytokines and inhibition of neomycin. Clin Exp Immunol. 86:1991;22-29.
20. Subauste CS, Dawson L, Remington JS. Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii. J Exp Med. 176:1992;1511-1519.
21. Resnick M, Roguel N, Bercovier H, Enk C, Frankenberg S, Kedar E. Lysis of murine macrophages infected with intracellular pathogens by interleukin 2 activated killer (LAK) cells in vitro. Cell Immunol. 113:1988;214-219.
22. Roder JC, Duwe AW. The beige mutation in the mouse selectively impairs natural killer cell function. Nature. 278:1979;451-453.
23. Kawase I, Brooks CG, Kuribayashi K, Olabuenaga S, Newman W, Gillis S, Henney CS. Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells. J Immunol. 131:1993;288-292.
24. Skamene E, Stevenson MM, Lemieux S. Murine malaria: dissociation of natural killer (NK) cell activity and resistance to Plasmodium chabaudi. Parasite Immunol. 5:1983;557-565.
25. Wood PR, Clark IA. Apparent irrelevance of NK cells to resolution of infections with Babesia microti and Plasmodium vinckei petteri in mice. Parasite Immunol. 5:1982;319-327.
26. Solomon JB, Forbes MG, Solomon GR. A possible role for natural killer cells in providing protection against Plasmodium berghei in early stages of infection. Immunol Lett. 9:1985;349-352.
27. Enriquez FJ, Sterling CR. Cryptosporidium infections in inbred strains of mice. J Protozool. 38:1991;100-102. (suppl).
28. Rasmussen KR, Healey MC. Experimental Cryptosporidium parvum infections in immunosuppressed adult mice. Infect Immun. 60:1992;1648-1652.
29. Schito ML, Barta JR, Chobotar B. Comparison of four murine Eimeria species in immunocompetent and immunodeficient mice. of special interest J Parasitol. 82:1996;255-262 A role for NK cell lytic function in the control of Eimeria papillata and E. ferrisi but not E. falciformis or E. veriformis infections was demonstrated by comparing parasite output in SCID/SCID and SCID/SCID.beige/beige mice. Highlights the utility of SCID/SCID.beige/beige mice for analyzing the role of lytic function in infectious disease models.
30. Rose ME, Hesketh P, Wakelin D. Cytotoxic effects of natural killer cells have no significant role in controlling infection with the intracellular protozoon Eimeria veriformis. Infect Immun. 63:1995;3711-3714.
31. Heyworth MF, Kung JE, Eriksson EC. Clearance of Giardia muris infection in mice deficient in natural killer cells. Infect Immun. 54:1986;903-904.
32. Hughes HP, Kasper LH, Little J, Dubey JP. Absence of a role for natural killer cells in the control of acute infection by Toxoplasma gondii oocysts. Clin Exp Immunol. 72:1988;394-399.
33. Johnson LL, Sayles PC. Strong cytolytic activity of natural killer cells is neither necessary nor sufficient for preimmune resistance to Toxoplasma gondii infection. of special interest Nat Immun. 14:1995;209-215 Demonstrates a dominant role for IFN-γ rather than lytic activity in control of T. gondii infection using beige and IFN-γ-deficient, mutant mice.
34. + cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice. J Exp Med. 178:1993;1465-1472.
35. Sher A, Oswald I, Hieny S, Gazzinelli RT. Toxoplasma gondii induces a T-independent IFN-gamma response in NK cells which requires both adherent accessory cells and TNF-alpha. J Immunol. 150:1993;3982-3989.
36. Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A. Interleukin 12 is required for T-lymphocyte-independent induction of interferon-gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA. 90:1993;6115-6119.
37. Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Caspar P, Trinchieri G, Sher A. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol. 153:1994;2533-2543.
38. of special interest Sher A, Denkers EY, Gazzinelli RT. Induction and regulation of host cell-mediated immunity by Toxoplasma gondii. Mitchison NA. CIBA Foundation Symposium. 1995;95-109 John Wiley and Sons, West Sussex, UK, Detailed review in which innate and adaptive host immune mechanisms against the intracellular protozoan T. gondii are discussed. Both T-cell-independent and T-cell-dependent pathways of resistance are described.
39. + cells are shown to contribute to local and systemic parasite control in SCID mice.
40. Kaye PM, Bancroft GJ. Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro. Infect Immun. 60:1992;4335-4342.
41. Varkila K, Chatelain R, Leal LMCC, Coffman RL. Reconstitution of C.B-17 Scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection. Eur J Immunol. 23:1996;262-268.
42. Scharton-Kersten T, Denkers EY, Gazzinelli R, Sher A. Role of IL12 in induction of cell-mediated immunity to Toxoplasma gondii. of special interest Res Immunol. 146:1996;539-545 Recent review on the contribution of IL-12 to host resistance against T. gondii: focussed primarily on the regulation of innate resistance.
43. + lymphocytes. Infect Immun. 61:1993;5174-5180.
44. Albierti JCS, Cardoso MAG, Martins GA, Gazzinelli RT, Vieira LQ, Silva JS. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. of outstanding interest Infect Immun. 64:1996;1961-1967 Interesting study documenting a role for IL-12 in resistance to T. cruzi. The authors shown that the induction of IL-12 by this parasite is stage-specific, that trypomastigotes but not epimastigotes are active and, in contrast to Toxoplasma gondii or Listeria monocytogenes, that live organisms are required to elicit the monokine response.
45. Cardillo F, Voltarelli JC, Reed SG, Silva JS. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. of special interest Infect Immun. 64:1996;128-134 Papers [45,47] are detailed descriptions of T-cell-independent immunity against Trypanosoma cruzi in euthymic and athymic mice.
46. Rottenberg M, Cardoni RL, Andersson R, Segura EL, Orn A. Role of T helper/inducer cells as well as natural killer cells in resistance to Trypanosoma cruzi infection. Scand J Immunol. 28:1988;573-582.
47. Hunter CA, Slifer T, Araujo F. Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon. of special interest Infect Immun. 64:1996;2381-2386 See annotation [45].
48. Sedegah M, Finkelman F, Hoffman SL. Interleukin 12 induction of interferon gamma-dependent protection against malaria. Proc Natl Acad Sci USA. 91:1994;10700-10702.
49. Chen W, Harp JA, Harmsen AG, Havell EA. Gamma interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice. Infect Immun. 61:1993;3548-3551.
50. McDonald V, Bancroft GJ. Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice. Parasite Immunol. 16:1994;315-320.
51. + T lymphocytes in protective immunity. J Immunol. 147:1991;1014-1022.
52. Bluman EM, Bartynski KJ, Avalos BR, Caligiur MA. Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines. of outstanding interest J Clin Invest. 97:1996;2722-2727 Provocative study suggesting that NK cells may contribute to the activation and recruitment of inflammatory cells via the production of chemokines.
53. Gazzinelli RT. Molecular and cellular basis of interleukin 12 activity in prophylaxis and therapy against infectious diseases. of special interest Mol Med Today. 2:1996;258-267 Comprehensive review of the practical uses of IL-12 in immunotherapy against infectious disease. The author highlights protozoan infections in which IL-12 treatment has proven beneficial in immunocompromised mice.
54. Akuffo H, Maasho K, Howe R. Natural and acquired resistance to Leishmania: cellular activation by Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of natural killer (NK) cells. Clin Exp Immunol. 94:1993;516-521.
55. Barral-Netto M, Barral A, Brodskyn C, Carvalho EM, Reed SG. Cytotoxicity in human mucosal and cutaneous leishmaniasis. of special interest Parasite Immunol. 17:1995;21-28 Evidence that NK cell lytic activity is enhanced in the peripheral blood of patients with cutaneous and mucosal leishmaniasis and that both IL-10 and transforming growth factor (TGF)-β can inhibit this response.
56. Sharma SD, Verhoef J, Remington JS. Enhancement of human natural killer cell activity by subcellular components of Toxoplasma gondii. Cell Immunol. 86:1984;317-326.
57. Scharton-Kersten T, Afonso LCC, Wysocka M, Trinchieri G, Scott P. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. of special interest J Immunol. 154:1995;5320-5330 Direct evidence supporting a central role for IL-12 in directing both innate and adaptive immune responses against Leishmania major is provided. Both resistant and susceptible mice are shown to produce IL-12 within the first few days of infection. Inhibition of IL-12 function in the latter animals is attributed to the regulatory activities of IL-4, IL-10 and TGF-β.
58. Scharton-Kersten TM, Wynn TA, Denkers EY, Bala S, Grunvald E, Hieny S, Gazzinelli RT, Sher A. In the absence of endogenous IFN-γ mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. of special interest J Immunol. 157:1996;4045-4054 Demonstration that the induction of IL-12 by T. gondii is IFN-γ independent in vivo. The parasite induced NK cell cytolytic response is characterized as requiring IL-12 but only partially dependent upon IFN-γ.
59. Skeiky YAW, Guderian JA, Benson DR, Bacelar O, Carvalho EM, Kubin M, Badaro R, Trinchieri G, Reed SG. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. of outstanding interest J Exp Med. 181:1995;1527-1537 First description of a defined parasite moiety with IL-12-inducing properties. Intriguingly, the protein is homologous to the eukaryotic ribosomal protein, elF4A.
60. Bate CA, Kwiatkowski D. A monoclonal antibody that recognizes phosphatidylinositol inhibits induction of tumor necrosis factor alpha by different strains of Plasmodium falciparum. Infect Immun. 62:1994;5261-5266.
61. Schofield L, Hackett F. Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J Exp Med. 177:1993;145-153.
62. Tachado SD, Schofield L. Glycosylphosphatidylinositol toxin of Trypanosoma brucei regulates IL-1 alpha and TNF-alpha expression in macrophages by protein tyrosine kinase mediated signal transduction. Biochem Biophys Res Commun. 205:1994;984-991.
63. Grunvald E, Chiramonte M, Hieny S, Wysocka M, Trinchieri G, Vogel SN, Gazzinelli RT, Sher A. Biochemical characterization and protein kinase C dependency of monokine inducing activities in Toxoplasma gondii. of special interest Infect Immun. 64:1996;2010 Description of biochemical properties of a soluble IL-12-inducing activity in T. gondii.
64. Hunter CA, Chizzonite R, Remington JS. IL-1β is required for IL-12 to induce production of IFN-γ by NK cells. J Immunol. 155:1995;4347-4354.
65. + T cells, actively contribute to the induced resistance.
66. Johnson LL, Gibson GW, Sayles PC. CR3-dependent resistance to acute Toxoplasma gondii infection in mice. of outstanding interest Infect Immun. 64:1996;1998-2003 A novel paper describing the role of the type 3 complement receptor in the induction of NK cell responses by T. gondii in vivo.
67. Biron CA, Gazzinelli RT. Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. of outstanding interest Curr Opin Immunol. 7:1995;485-496 A detailed review on the beneficial and detrimental effects of IL-12 on immunity to a number of infectious agents with an emphasis on the regulation of NK cell activation and effector functions.
68. Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 378:1995;88-92.
69. Evans DL, Leary JH III, Weisman Z, Warren J, Jaso Friedman L. Mapping the epitope recognized by non-specific cytotoxic cells: determination of the fine specificity using synthetic peptides. Scand J Immunol. 43:1996;556-565.
70. Raulet DH. Recognition events that inhibit and activate natural killer cells. Curr Opin Immunol. 8:1996;372-377.
71. Hunter CA, Bermudez L, Beernink H, Waegell W, Remington JS. Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii. of special interest Eur J Immunol. 25:1995;994-1000 An important paper demonstrating that TGF-β antagonizes the protective effects of IL-12 in immunodeficient mice infected with T. gondii. In vitro analyses indicate that TGF-β directly inhibits NK cell function.
72. + T cells and accompanied by overproduction of IL-12, IFN-gamma, and TNF-alpha. of outstanding interest J Immunol. 157:1996;798-805 The unexpected lethality of T. gondii in IL-10 knockout mice is attributed to an exaggerated type I cytokine response rather than unchecked parasite replication. The study argues that IL-10 is required for the down-modulation of T. gondii-induced cell-mediated immunity and illustrates the potent regulatory effects of this cytokine in vivo.
73. Tripp CS, Wolf SF, Unanue ER. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA. 90:1993;3725-3729.
74. Carrera L, Gazzinelli RT, Badolato R, Hieny S, Muller W, Kuhn R, Sacks DL. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med. 183:1996;515-526.
75. Barral-Netto M, Barral A, Brownell CE, Skeiky YA, Ellingsworth LR, Twardzik DR, Reed SG. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science. 257:1992;545-548.
76. Stenger S, Thuring H, Rollinghoff M, Bodgan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J Exp Med. 180:1994;783-793.
77. Dandrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin-10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med. 178:1993;1041-1048.
78. Urban JF Jr, Fayer R, Chen S-J, Gause WC, Gately MK, Finkelman FD. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J Immunol. 156:1996;263-268.
79. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK. Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med. 177:1993;1505-1509.
80. Sypek JP, Chung CL, Mayor SEH, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med. 177:1993;1797-1802.
81. Nabors GS, Afonso LCC, Farrell JP, Scott P. Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by a combined therapy with interleukin-12 and Pentostam. Proc Natl Acad Sci USA. 92:1994;3142-3145.
82. + and NK cells. Moreover, a role for IFN-γ, IL-2 and TNF is indicated.
83. Stevenson MM, Tam MF, Wolf SF, Sher A. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via nitric oxide-dependent mechanism. J Immunol. 155:1995;2545-2556.
84. Hunter CA, Candolfi E, Subauste C, Van Cleave V, Remington JS. Studies on the role of interleukin-12 in acute murine toxoplamosis. Immunology. 84:1996;16-20.
85. Khan I, Matsuura T, Kasper LH. Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect Immun. 62:1994;1639-1642.
86. Afonso LCC, Scharton T, Vieira LQ, Wysocka M, Trinchieri G, Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science. 263:1994;235-237.